Expression and characterization of mouse lactate dehydrogenase subunit C in Escherichia coli.

Objective: To construct a prokaryotic recombinant vector for mouse lactate dehydrogenase-C and to detect its expression in BL21. Methods: The coding sequence of mouse lactate dehydrogenase subunit C was amplified from mouse testis RNA with specific primers and cloned into pGEX-2T after restriction digestion with BamH I and EcoR I. GST fusion protein was expressed after induction with IPTG. Results: Sequencing and restriction digestion of the recombinant plasmid revealed the coding sequence for mouse lactate dehydrogenase subunit C. A protein band of about 60 000 could be induced by IPTG in the recombinant plasmid. Conclusion: The coding sequence of mouse lactate dehydrogenase subunit C was introduced into the pGEX-2T plasmid and a GST-fused protein could be induced at a high level.     

Development of a mouse model for nonbacterial chronic prostatitis induced by immunizator and adjuvant

In order to develop an animal model for nonbacterial chronic prostatitis(NBCP), prostate tissues were obtained from freshly pooled prostates of SDrats. The final concentration of the antigen (prostate tissue protein) was di-luted to 0.1, 0.3, 0.5 and 1.0 mg/0.5 mL, and then emulsified with andequal volume of Freund's complete adjuvant (CFA). The purified antigen     

Gene cloning of human soluble CD14 and its expression ineucaryotic cells

Objective: To express human soluble CD14 (sCD14) in eukaryotic cens. Methods : Human sCD14 cDNA was amplified from U937 cells with RT-PCR method. The recombinant expression plasmid pEFI/HisC/sCD14^348ss was constructed and the expression in COS-7 cells was carried out using liposome transfection method. The yield was examined with scanning map identification. The expressed product was purified by immuno-affinity chromatography. Results: Sequence analysis demonstrated that the amplified gene sequence and those reported by documents were completely identical, sCD14 was expressed with highyield. The expressed product was purified to above 90%.Recombinant sCDI4, specifically combinable with endotoxins, had a natural biological activity. Conclusions: Human sCD14 was expressed in COS-7 cells, which laid a foundation for further study.     

The preparation and application of N-terminal 57 amino acid protein of the follicle-stimulating hormone receptor as a candidate male contraceptive vaccine

Follicle-stimulating hormone receptor （FSHR）, which is expressed only on Sertoli cells and plays a key role in spermatogenesis, has been paid attention for its potential in male contraception vaccine research and development. This study introduces a method for the preparation and purification of human FSHR 57-amino acid protein （FSHR-57aa） as well as determination of its immunogenicity and antifertility effect. A recombinant pET-28a（＋）-FSHR-57aa plasmid was constructed and expressed in Escherichia coil strain BL21 StarTM （DE3） and the FSHR-57aa protein was separated and collected by cutting the gel and recovering activity by efficient refolding dialysis. The protein was identified by Western blot and high-performance liquid chromatography analysis with a band of nearly 7 kDa and a purity of 97.4%. Male monkeys were immunized with rhFSHR-57aa protein and a gradual rising of specific serum IgG antibody was found which reached a plateau on day 112 （16 weeks） after the first immunization. After mating of one male with three female monkeys, the pregnancy rate of those mated with males immunized against FSHR-57aa was significantly decreased while the serum hormone levels of testosterone and estradiol were not disturbed in the control or the FSHR-57aa groups. By evaluating pathological changes in testicular histology, we found that the blood-testis barrier remained intact, in spite of some small damage to Sertoli cells. In conclusion, our study demonstrates that the rhFSHR-57aa protein might be a feasible male contraceptive which could affect sperm production without disturbing hormone levels.     

靶向大鼠诱导型一氧化氮合酶基因的shRNA重组腺病毒载体的构建及鉴定

目的 构建携带增强型绿色荧光蛋白基因(EGFP)标志针对大鼠诱导型一氧化氮合酶(iNOS)基因的shRNA重组腺病毒载体并在人胚肾-293细胞中扩增制备重组病毒.方法 利用AdMax包装系统,用先期构建的带有EGFP标记基因的穿梭质粒pDC316-iNOS-shRNA-EGFP,与骨架质粒pBHGlox_El,3Cre共转染293包装细胞,同源重组产生复制缺陷型重组腺病毒载体Ad5-inosshRNA-EGFP,反复感染293细胞扩增病毒后,离子交换法纯化病毒,并测定病毒颗粒数及滴度.结果 经聚合酶链反应(PCR)检测和EGFP表达证明已成功构建了携带iNOS-shRNA-EGFP的重组腺病毒载体;扩增纯化后,测得重组腺病毒颗粒数为3.6×1011 VP/ml,A260/A280值约为1.25,病毒活性为7.94×109IU/ml.结论 已成功构建重组腺病毒载体Ad5-inos-shRNA-EGFP,为利用基因激活技术治疗勃起功能障碍的研究奠定实验基础.

Abstract：

Objective To construct an adenovirus vector expressing short hairpin RNA (shRNA)of rat inducible oxide synthase (iNOS) carrying enhanced green fluorescent protein (EGFP) and amplify the adenovirus vector in HEK-293 cells. Methods The shuttle plasmid pDC316-inos-shRNA-EGFP that was constructed at an earlier date, was cotransfected with the adenovirus skeleton plasmid pBHGlox_E1,3Cre into 293 cells to obtain the produced replication defective recombinant adenovirus vector Ad5-inosshRNA-EGFP. The recombinant adenovirus was propagated by repeat infection of 293 cells and purified by ion exchange method, then the virus particles were counted and the purity and titer were determined.Results Recombinant adenoviral vector Ad-ACE-shRNA was constructed successfully, which was confirmed by polymerase chain reaction (PCR) and GFP expression. After amplification and purification, the virus particle count, A260/A280 and titer of recombinant adenovirus were 3.6 × 1011 VP/ml, 1.25 and 7.94 ×109 IU/ml,respectively. Conclusion Recombinant adenovirus vector Ad5-inos-shRNA-EGFP is successfully constructed, which laid a foundation for gene activation in erectile dysfunction treatment.     

Inhibition of mouse acrosome reaction and sperm-zona pellucida binding by anti-human sperm membrane protein 1 antibody

Aim： To investigate the possible functions of human sperm membrane protein （hSMP-1） in the process of fertilization. Methods： A 576-bp cDNA fragment of HSD-1 gene coding for the extracellular domain of hSMP-1 was cloned and expressed. The localization of this protein on human and mouse sperm was determined by indirect immunofluorescent staining by using anti-recombinant hSMP-1 （anti-rhSMP-1） antibodies. Sperm acrosome reaction and spermzona pellucida （ZP） binding assay were carried out in 10-week-old BALB/c mice. Results： Recombinant hSMP-1 was successfully cloned and expressed. The expression of the native protein was limited on the acrosome of human and mouse sperm. Treatment of anti-rhSMP-1 antibodies significantly decreased the average number of sperms bound to each egg. Meanwhile, the percentage of acrosome reaction was decreased in comparison to pre-immune control after treatment with anti-rhSMP-1 （P 〈 0.05）. Conclusion： The results suggest that anti-rhSMP-1 antibody inhibited mouse acrosome reaction and sperm-ZP binding.